Clinical Trial Update: Standard Therapy With or Without Dalteparin in Treating Patients With Advanced Breast, Lung, Colorectal, or Prostate Cancer [Phase 3]

View source ↗

Summary

This Phase 3 trial evaluates whether adding dalteparin to standard therapy improves outcomes in patients with advanced breast, lung, colorectal, or prostate can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer
• Lung Cancer
• Prostate Cancer

Drugs mentioned

• Dalteparin (dalteparin)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Breast Cancer, Colorectal Cancer | Phase 3 | Status: COMPLETED